
Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 78.9, indicating a potential upside of 24.3% from the current price of HKD 63.5 [4][10]. Core Insights - The company achieved a significant revenue growth of 120%-125% year-on-year in Q3 2024, surpassing market expectations, and demonstrating strong operational capabilities in IP management and global expansion potential [2][3]. - The report highlights a robust performance in the Chinese market, with revenue growth of 55%-60% in Q3 2024, compared to 32% in the first half of the year, showcasing the company's resilience in a challenging economic environment [2][7]. - Internationally, the company reported an impressive 440%-445% revenue growth in Q3 2024, further validating its global expansion strategy and the effectiveness of its IP monetization efforts [2][7]. Financial Performance Summary - Revenue projections for 2024-2026 have been revised upwards by 20%-31%, with net profit estimates increased by 24%-36% [2][8]. - The company is expected to generate revenues of RMB 12,395 million in 2024, RMB 17,733 million in 2025, and RMB 22,156 million in 2026, reflecting growth rates of 96.7%, 43.1%, and 24.9% respectively [3][5]. - The net profit for 2024 is projected at RMB 2,599 million, with a significant year-on-year increase of 140.1% [3][5]. Market Position and Valuation - The current valuation stands at 18.8 times the estimated P/E for 2025, with a PEG ratio of approximately 0.3, indicating that the stock remains attractive compared to other consumer stocks in China [2][3]. - The company’s strong IP incubation capabilities and optimistic outlook for international markets contribute to a strong long-term growth trajectory [2][3].